100+ evaluation scenarios
Standard public/synthetic/de-identified genomic scenarios were used to test review package generation and safety boundaries.
Prepared for controlled pilot readiness, not an autonomous clinical system.
Tynixa completed an internal governed evaluation program across public, synthetic, and de-identified genomic scenarios. These highlights support controlled pilot readiness and do not represent external clinical validation.
10 critical stress cases
Critical and complex case patterns were used to verify escalation, missing evidence detection, and human review requirements.
18 adversarial package tests
Adversarial review-package challenges were used to reduce overconfidence and preserve safety boundaries.
128 review package validations
Review package checks evaluated completeness, evidence depth, conflict usefulness, and review-readiness.
Commercial readiness signal
Controlled Pilot Ready: Tynixa is ready for selected controlled pilot discussions using public, synthetic, or de-identified cases. Human review remains required.
What this does not claim
This summary does not claim autonomous diagnosis, final diagnosis, final ACMG classification, treatment recommendation, PHI processing, clinical release, or external clinical validation.
Explore Controlled Pilot